In 2023, the trade exchange (includes international purchases and sales) of Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined was US$33.8M.
In 2023, the states with the most international sales in Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined were Estado de México (US$3.86M) and Ciudad de México (US$35.4k).
The states with the most international purchases in 2023 were Ciudad de México (US$8.79M), Estado de México (US$7.82M), Jalisco (US$3.56M), Nuevo León (US$1.12M), and Tamaulipas (US$145k).
In 2023, the main commercial destinations of Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined were Canada (US$3.15M), United States (US$680k), Cuba (US$62.5k), Colombia (US$444), and Argentina (US$335).
The main commercial origins of Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined in 2023 were United States (US$13.3M), Brazil (US$5.91M), Argentina (US$582k), India (US$555k), and Germany (US$256k).
In the global context, the main exporting countries of Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined in 2022 were Germany (US$225M), Netherlands (US$210M), and India (US$195M). In the same year, the main importing countries of Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined were Netherlands (US$252M), United States (US$129M), and Germany (US$94.5M).